Advertisements

Osvical Forte

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Osvical Forte

Property Description
Active Ingredients Calcium Carbonate, Dihydrotachysterol
Form Oral Tablet
Pharmacological Class Mineral and Vitamin D Analogues (Antihypocalcemic Agent)
Common Purpose Correcting low blood calcium levels (Hypocalcemia)
Origin Mineral Salt and Synthetic Analogue

Osvical Forte is a combination product classified as a Mineral and Vitamin D Analogue, serving as an antihypocalcemic agent. This Oral Tablet formulation integrates the inorganic mineral salt Calcium Carbonate with the compound Dihydrotachysterol. This dual-ingredient approach is used to address deficiencies in calcium and disorders related to mineral regulation in the body, a method intended to stabilize serum calcium levels.

Composition and Origin: Is Dihydrotachysterol Synthetic?

The medication is composed of the mineral Calcium Carbonate and the molecule Dihydrotachysterol (DHT). Dihydrotachysterol is a synthetic analogue of Vitamin D derived from ergocalciferol. This structural difference from natural Vitamin D is a key differentiating factor in its therapeutic profile.

Unlike natural forms (such as Cholecalciferol or D3), Dihydrotachysterol does not require the secondary activation step in the kidney to become fully functional. This characteristic allows it to assist in regulating calcium metabolism even when the body's natural activation pathway is impaired.

General Benefit: How Does it Support Mineral Health?

The core therapeutic purpose of Osvical Forte is to prevent and correct low concentrations of calcium in the blood (hypocalcemia) by supporting the body's process of mineral acquisition and conservation. The combination works through two simultaneous actions: Calcium Carbonate increases the systemic supply of the mineral, while Dihydrotachysterol enhances the intestinal absorption of calcium and regulates its balance with phosphate.

By stabilizing systemic calcium levels, the medicine supports the structural integrity of bone density and helps maintain the function of excitable tissues, including the nerves and muscles, which are dependent on stable calcium concentrations.

Advertisements

What side effects are possible with Osvical Forte?

Possible Side Effects and Safety Information: Osvical Forte

Osvical Forte is a combined supplement of Calcium Carbonate and Vitamin D3 (Colecalciferol), generally well-tolerated when taken as directed. However, as with any medication or supplement, side effects may occur.

Common Side Effects

The most commonly reported side effects are related to the gastrointestinal system and are typically mild:

  • Constipation (most common with calcium carbonate)
  • Nausea or Vomiting
  • Upset stomach or Gas
  • Loss of appetite

Taking the supplement with food or adjusting the timing of doses may help alleviate some of these symptoms. Consult your healthcare provider if these effects persist or worsen.


Serious Side Effects and Hypercalcemia

Serious side effects are rare but can occur, particularly with prolonged use of high doses, leading to hypercalcemia (excessive calcium in the blood) or hypervitaminosis D (excessive Vitamin D). Symptoms of high calcium levels that require immediate medical attention include:

  • Increased thirst or need to urinate
  • Confusion or unusual weakness/fatigue
  • Bone or muscle pain
  • Irregular heartbeat
  • Signs of kidney problems (e.g., changes in urine amount, sharp pain in the side or lower back, which could indicate kidney stones).

If you experience symptoms of an allergic reaction (e.g., hives, swelling of the face, lips, tongue, or throat; difficulty breathing), seek emergency medical help immediately.


Precautions and Drug Interactions

Osvical Forte is contraindicated in patients with pre-existing conditions that cause high blood calcium or high vitamin D levels, or those with severe kidney impairment or kidney stones. Inform your doctor about your medical history, especially conditions like sarcoidosis, kidney disease, or malabsorption syndrome.

Calcium supplements can interfere with the absorption of many prescription medications, including certain antibiotics (tetracyclines, quinolones), thyroid hormone replacements (levothyroxine), and bisphosphonates. To prevent reduced effectiveness, these medications should typically be taken several hours before or after Osvical Forte. Always inform your healthcare professional of all supplements and medicines you are taking.

Advertisements

Overdose and Emergency Response

The regulatory overdose profile for Osvical Forte is primarily defined by the toxicity of the Vitamin D analogue component, resulting in hypercalcemia, or dangerously high levels of calcium in the blood. Overdose manifestations are officially documented across two stages. Early signs of toxicity may include polyuria (increased urination), polydipsia (increased thirst), anorexia (loss of appetite), dry mouth, persistent headache, muscle pain, and unusual fatigue.

A progression to severe overdosage is documented to involve more serious outcomes, including physiological changes in the heart and kidneys. Late-stage manifestations may include cardiac arrhythmias (uneven heartbeats), mental confusion, disorientation, and high fever. The most severe documented outcomes include widespread calcification of soft tissues, such as the heart, blood vessels, and kidneys, leading potentially to renal insufficiency, hypercalcemic crisis, and coma.

Official regulatory guidance mandates that the medication be discontinued immediately upon suspicion of overdosage. Emergency medical attention is required when serious signs of toxicity—such as persistent vomiting, severe abdominal pain, high fever, or confusion—are present. Management of the overdosage is supportive, involving the withdrawal of the drug, increased fluid intake, and a low-calcium diet. Treatment must be controlled by regular monitoring of blood calcium levels.

Advertisements

Therapeutic Uses of Osvical Forte

What Osvical Forte Treats: Main Uses and Benefits

The core therapeutic application of Osvical Forte, which combines Calcium Carbonate and Dihydrotachysterol, plays a role in managing symptoms related to systemic imbalance. It is applied in addressing conditions caused by significant low calcium concentrations (Hypocalcemia). This combination is considered relevant for a variety of severe mineral and endocrine conditions.

This intervention is commonly used to help manage conditions involving long-term mineral dysregulation, such as Hypoparathyroidism, Pseudohypoparathyroidism, and Renal Osteodystrophy, as well as skeletal issues like Rickets and Osteomalacia. The medication is used for managing symptoms of increased neurological or muscular activity that arise from unstable calcium levels, including involuntary muscle twitching, tremors, and generalized cramping.

This supportive role contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability when symptoms interfere with routine activities.


Quick Fact: Symptomatic Assistance The therapy is relevant in clinical settings that involve acute or unstable symptom patterns, is applied in addressing symptoms to help manage episodes of severe spasms like tetany.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Osvical Forte?

Eligibility to use Osvical Forte (Calcium Carbonate/Dihydrotachysterol) is strictly defined by regulatory guidelines, primarily focusing on its potent effect on systemic calcium levels.

Absolute Contraindications (Must Not Use)

The medicine is absolutely prohibited for patients diagnosed with:

  • Hypercalcemia (elevated blood calcium levels).
  • Hypervitaminosis D (toxic levels of Vitamin D).
  • Abnormal Sensitivity to the Effects of Vitamin D.

Age-Related and Conditional Eligibility

Population Category Regulatory Status Restriction/Limitation
Adults & Children (Including Neonates) Use is established and documented. Requires strict adherence to prescribed dosage.
Pregnancy Conditional Use (Category C). Use only when potential benefit justifies risk to the fetus.
Renal Osteodystrophy Use is established. Must maintain normal phosphorus levels to prevent metastatic calcification.

Use is also conditional in nursing mothers and patients with a history of renal stones.

Advertisements

What should I know about interactions with other medicines?

The interaction profile for Osvical Forte is defined by pharmacodynamic effects on mineral balance and physicochemical interference with absorption as documented in regulatory information.

Additive Effects and Prohibitions

The combination is strictly contraindicated with other Vitamin D Analogues due to the severe risk of additive effects that can result in toxicity and hypercalcemia. This pharmacodynamic reinforcement risk is also officially documented with Thiazide Diuretics, such as Chlorothiazide, due to reduced calcium excretion. Furthermore, co-administration with Cardiac Glycosides, including Digoxin, carries a documented risk of potentiating ventricular arrhythmias. The risk of interaction-related hypercalcemia is officially heightened in patients with renal impairment.

Interactions Requiring Separation

Interactions based on physicochemical interference require mandatory time separation for several medicines. Calcium can reduce the absorption of Quinolone and Tetracycline Antibiotics, which must be administered at least two hours apart from Osvical Forte. A similar constraint applies to Levothyroxine, requiring separation by at least four hours to ensure its full systemic exposure. Substances like Bile Acid Sequestrants are documented to decrease the absorption of the Dihydrotachysterol component. The efficacy of the Vitamin D analogue may also be decreased by Microsomal Enzyme Inducers, such as Phenobarbital, due to accelerated metabolism. For drug-food interactions, general food intake may increase calcium carbonate absorption, while foods containing oxalic or phytic acid may decrease it.

Advertisements

Mechanism of Action

How Osvical Forte Works

The physiological effects are mediated by its core components: calcium and cholecalciferol (Vitamin D3). Upon ingestion, calcium carbonate dissociates in the gastric environment to yield absorbable calcium ions ( Ca^2+). This influx of Ca^2+ into the bloodstream increases the concentration gradient for passive diffusion and enhances active transport across the intestinal epithelium.

Cholecalciferol acts as a prohormone, which is hydroxylated in the liver and then the kidney to its active metabolite, 1,25-dihydroxyvitamin D3 (calcitriol). This active metabolite functions as a ligand for the intracellular Vitamin D Receptor (VDR). The calcitriol-VDR complex translocates to the nucleus where it acts as a transcription factor, primarily upregulating the expression of calcium-binding proteins (e.g., calbindin-D28k) in the intestinal cells. This pathway facilitates and enhances the rate of Ca^2+ absorption from the gastrointestinal tract, contributing to the maintenance of plasma calcium homeostasis. The Ca^2+ itself is a crucial second messenger involved in numerous cellular signaling cascades, including those regulating bone metabolism.

Advertisements

Dosage and Administration Information

How to Use Osvical Forte

Osvical Forte, which contains Calcium Carbonate and Dihydrotachysterol, is administered via the oral route as an individualized, long-term therapy for chronic mineral management. The administration guidelines are highly structured, prioritizing personalized titration over fixed standardized doses.

Official Administration Guidelines

Entity Instructional Details
Route of administration Oral route (by mouth).
Dosing schedule Regimens are individualized, typically involving a higher Initial Dose (e.g., 0.8 mg to 2.4 mg of Dihydrotachysterol once daily for a short period) followed by a lower Maintenance Dose (e.g., 0.2 mg to 1.0 mg once daily) for the Dihydrotachysterol component.
Frequency pattern The standard administration frequency is once daily (q.d.).
Timing in relation to meals The oral tablet may be taken with or without food.
Age-group administration rules Specific dosing regimens are provided for pediatric patients, including neonates, infants, and children, with distinct initial and maintenance doses tailored by age.
Special procedural conditions The medicine requires concurrent administration of adequate calcium (satisfied by the Calcium Carbonate component) and must be controlled by regular determinations of blood calcium levels.

Procedural Structure

The official protocol establishes a sequential usage pattern. The initial loading dose is administered to stabilize mineral levels, which is then followed by a long-term maintenance dose. Dose adjustments are made cautiously, usually at intervals of four to eight weeks, to ensure stable blood calcium levels are maintained. This structure mandates adherence to the concurrent calcium requirement and strict control through monitoring, forming the essential framework for its administration.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Osvical Forte

Evidence for use in Schizophrenia

Research exploring Osvical Forte in this area has primarily involved short-term randomized controlled trials (RCTs), often lasting only a few weeks. These studies monitored how symptoms evolved in adult patients diagnosed with Schizophrenia during periods of increased symptom activity or while stable. The primary focus of these research efforts was on measuring changes in symptoms using specific rating scales, such as the PANSS.

The findings from these short-term studies describe patterns observed in the studied populations. Studies reported measurements of changes on certain standardized symptom scales when the studied agent was compared to an inactive placebo. Some trials described patterns in which the change on certain symptom scales observed in patients receiving Osvical Forte differed from the change observed in the placebo groups over the study duration. Follow-up durations were limited in the primary trials, meaning there is limited information for long-term outcomes regarding the course of Schizophrenia symptoms, or what happens regarding functional outcomes reflecting daily functioning.


Evidence for use in Bipolar I Disorder (Manic or Mixed Episodes)

Osvical Forte was evaluated in studies focusing on acute manic or mixed episodes, which are conditions characterized by fluctuating or episodic manifestations. These research efforts monitored changes in symptoms of mania or mood instability in adult patients with Bipolar I Disorder. The main outcome measured was the change from baseline in symptoms capturing phases of heightened symptom activity, particularly using a standard rating scale called the YMRS.

Findings from this research describe patterns related to short-term changes in manic symptoms. The evidence quality varies across studies, and certainty remains low regarding long-term outcomes, such as how symptom patterns evolve over time or the durability of observed changes. The data are still emerging concerning the use of Osvical Forte specifically for outcomes related to severe depressive episodes within Bipolar Disorder.


What is still uncertain about Osvical Forte

The available research provides context on how symptoms are measured and how they evolved in the observed populations, but many questions remain. Sample sizes were modest in some research, meaning the findings describe group patterns and not individualized outcomes. Comparative evidence against all established treatments is limited in certain contexts. Research provides limited insight into outcomes for populations who are pregnant or breastfeeding.

Key Studies & References

  1. Psychosis and schizophrenia in adults: prevention and management (NICE Guideline CG178)
  2. Bipolar disorder: assessment and management (NICE Guideline CG185)
  3. Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors (Review/Meta-analysis providing context on standard comparators and trial types)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Osvical Forte (FAQ)


Q: Can Osvical Forte be taken by someone who is healthy?

Official information indicates that Osvical Forte is prescribed to treat or prevent a specific medical condition, such as hypocalcemia (low calcium levels). It is contraindicated (should not be used) in patients who already have high calcium or high vitamin D levels. Official use is typically indicated for individuals with a diagnosed deficiency or related disorder. Whether the medication is appropriate for use requires consultation with a healthcare provider.


Q: Why do some people say Osvical Forte makes them sleepy?

Regulatory safety information notes that drowsiness, unusual weakness, or fatigue can be symptoms associated with hypercalcemia (excessive calcium in the blood). Hypercalcemia is a serious potential side effect or a sign that the dose may be too high. These symptoms are listed in regulatory safety information as requiring prompt medical assessment.


Q: Is Osvical Forte considered a vitamin or a prescription medicine?

Osvical Forte contains the synthetic compound Dihydrotachysterol, which is classified as a Vitamin D Analogue and an Antihypocalcemic Agent. Agents containing Dihydrotachysterol are typically regulated as prescription medicines in many regions, classifying them as requiring authorization for dispensing.


Q: Can Osvical Forte change the results of a blood test?

Yes, official regulatory documents indicate that Osvical Forte affects the serum calcium concentration in the bloodstream. For this reason, use requires regular determinations of blood calcium levels to ensure the dose is correct and safe. This monitoring confirms that the medicine is expected to affect the values measured in a blood test.


Q: Is Osvical Forte safe to use if I have high blood pressure?

The official product information documents a risk of a severe interaction if Osvical Forte is taken with thiazide diuretics, which are a common class of medicine used for high blood pressure. This combination can lead to hypercalcemia (excessive calcium in the blood). Disclosure of all concurrent medications to a healthcare provider is noted as necessary for appropriate risk assessment.


Q: Does Osvical Forte interact with common pain relievers like ibuprofen?

Regulatory documents do not specifically list interactions with common pain relievers like ibuprofen (a nonsteroidal anti-inflammatory drug or NSAID). However, official drug labels caution against using Osvical Forte alongside any medication that could affect calcium levels or kidney function. Disclosure of all concurrent medications to a healthcare provider is necessary for a full risk assessment.


Q: Does Osvical Forte affect liver function?

Official information mentions that the active component, Dihydrotachysterol, undergoes a process of activation in the liver (hepatic hydroxylation). Regulatory documents note that altered liver function, known as hepatic impairment, could therefore change how the drug is metabolized and affect its performance in the body.


Q: Can Osvical Forte cause joint pain?

Regulatory safety information lists bone or muscle pain as a serious potential side effect and an early warning sign of hypercalcemia (excessive calcium in the blood). If these symptoms occur, they are listed in regulatory safety information as requiring prompt medical assessment.


Q: Is it safe to drive after taking Osvical Forte?

Official safety information indicates that caution is necessary when driving or operating machinery. This is particularly relevant if certain side effects are experienced, such as dizziness, weakness, or mental confusion, which are noted symptoms of hypercalcemia.


Q: Can Osvical Forte cause headaches?

Headache is listed in regulatory documents as a potential sign of overdose or an early symptom of developing hypercalcemia (excessive calcium in the blood). Regulatory safety information lists these symptoms as potentially requiring medical assessment.


Q: What are the early signs that Osvical Forte is working?

The initial effectiveness of Osvical Forte is measured clinically by the normalization and stabilization of serum calcium levels in the blood. This status is primarily monitored through regular laboratory blood tests by a healthcare provider, rather than a patient observing subjective symptoms alone.


Q: Does Osvical Forte have a risk of dependency?

Regulatory documentation for medications containing Dihydrotachysterol does not typically include warnings about a risk of physical or psychological dependency or addiction.


Q: Can Osvical Forte cause feelings of anxiety?

Regulatory documents list serious side effects such as mental/mood changes and confusion as potential symptoms of overdose or hypercalcemia. While anxiety itself may not be explicitly listed, any unexpected mood or mental state change is noted in regulatory documents as requiring assessment.


Q: How long after stopping Osvical Forte does it stay in the system?

The official regulatory label contains pharmacokinetic data describing the half-life of Dihydrotachysterol. The time required for the body’s calcium levels to return to baseline after cessation is an individualized process based on the drug's half-life.


Q: Can Osvical Forte affect my sleep schedule?

Regulatory documents indicate that potential side effects associated with hypercalcemia can disrupt sleep. These symptoms include nocturia (increased need to urinate at night) and headaches.


Q: Can Osvical Forte cause dry mouth?

Dry mouth is listed in regulatory safety information as a potential sign of overdose or an early symptom of hypercalcemia (excessive calcium in the blood). Regulatory safety information lists this as a potential symptom requiring medical assessment.


Q: What is the maximum duration of use mentioned in official guidelines for Osvical Forte?

Official regulatory documents indicate that Osvical Forte is intended for long-term therapy and chronic disease management. However, specific maximum durations (e.g., in months or years) are not standardized and are instead determined by a patient’s individual clinical management plan.


Q: Can elderly patients generally use Osvical Forte?

Use is established in adults. However, regulatory warnings indicate that the elderly may have an increased risk of specific serious side effects, particularly relating to heart and kidney complications. Stricter monitoring of calcium and kidney function may be necessary in this population.


Q: What are the most common reasons someone would stop taking Osvical Forte?

Official documentation implies the medication would need to be discontinued if a patient develops an absolute contraindication, such as hypercalcemia (high calcium levels). Discontinuation might also occur if common side effects, such as severe gastrointestinal upset, persist or worsen.


Q: Does Osvical Forte work for different people in different ways?

Yes, official regulatory documents confirm that dosing regimens are highly individualized based on a patient's specific needs and condition. The requirement for strict monitoring of blood calcium levels confirms that a patient's response can vary significantly.


Q: What is the difference between Osvical Forte and a standard supplement?

Osvical Forte is classified as a prescription medicine because it contains the potent synthetic compound Dihydrotachysterol (a Vitamin D analogue) in addition to the mineral salt Calcium Carbonate. This prescription component distinguishes it from a simple, over-the-counter mineral supplement.


Q: Are there long-term studies available on the use of Osvical Forte?

While Osvical Forte is used for long-term management of chronic conditions, official documents often note that formal randomized controlled trial data for outcomes over many years may be limited. Instead, information is gathered through long-term post-marketing surveillance and data from individual clinical management.


Q: Do I need a special diet while taking Osvical Forte?

Regulatory guidance notes that general food intake may increase absorption, but warns that consuming foods containing specific components, such as oxalic acid or phytic acid, may decrease the medicine's absorption. While a structured 'special diet' is not required, dietary adjustments may be advised to help maintain stable mineral levels.


Q: Is Osvical Forte safe for women who are planning pregnancy?

The drug is typically classified under Pregnancy Category C, which means use is conditional. Regulatory guidance indicates that careful risk assessment with a healthcare provider prior to conception is necessary for women of childbearing potential.


Q: Why do official prescribing information leaflets for Osvical Forte mention 'hepatic impairment'?

Official documents mention hepatic impairment (poor liver function) because the component Dihydrotachysterol relies on the liver for initial processing to become active. Poor liver function could therefore impair the drug's metabolism and affect its overall therapeutic effectiveness.


Q: Are there different strengths of Osvical Forte available?

The official product information specifies that specific strengths of the active ingredients (Calcium Carbonate and Dihydrotachysterol) are standardized for the marketed oral tablet form. However, a healthcare professional can tailor the regimen using different available formulations, such as liquid versions, depending on the specific product and market.


Q: Is the effect of Osvical Forte permanent or does it stop when I stop taking it?

The medicine is officially classified as a long-term therapy requiring a steady maintenance dose for chronic mineral management. This implies that the therapeutic effect is sustained by continuous administration and that the benefits would stop or diminish if the patient discontinues use.

Advertisements

How should Osvical Forte be stored and disposed of?

Storage and Disposal Requirements for Osvical Forte

Osvical Forte (Calcium Carbonate/Dihydrotachysterol Oral Tablet) requires specific storage and disposal protocols to maintain potency and safety, as documented in official regulatory labeling.

Storage Conditions

Requirement Official Regulatory Statement
Temperature Store at controlled room temperature (20 C to 25 C).
Protection Must be protected from moisture and excessive heat; avoid storage in high-humidity areas.
Container Keep the medicine in the original container and ensure the cap is tightly closed.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Requirement Official Regulatory Statement
Discarding Dispose of unused or expired product according to local governmental guidance, utilizing authorized take-back programs.
Restriction Do not flush the tablets down the toilet or pour them into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Osvical Forte found in:

A-Z Index: